Three-year treatment of familial heterozygous hypercholesterolemia by extracorporeal low-density lipoprotein immunoadsorption with polyclonal apolipoprotein B antibodies
- 31 July 1993
- journal article
- Published by Elsevier in Metabolism
- Vol. 42 (7) , 888-894
- https://doi.org/10.1016/0026-0495(93)90065-v
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Familial hypobetalipoproteinemia and familial defective apolipoprotein B100Current Opinion in Lipidology, 1990
- Treatment of familial hypocholesterolemia by means of specific immunoadsorptionJournal of Clinical Apheresis, 1988
- Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT)JAMA, 1986
- Regression der Koronarsklerose bei familiärer Hypercholesterinämie IIa durch spezifische LDL-AphereseDeutsche Medizinische Wochenschrift (1946), 1986
- Epidemiology of coronary heart disease: The Framingham studyThe American Journal of Medicine, 1984
- The Lipid Research Clinics Coronary Primary Prevention Trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol loweringJAMA, 1984
- The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart diseaseJAMA, 1984
- APPLICATION OF SPECIFIC EXTRACORPOREAL REMOVAL OF LOW DENSITY LIPOPROTEIN IN FAMILIAL HYPERCHOLESTEROLAEMIAThe Lancet, 1981
- Plasma-Exchange Therapy of Homozygous Familial HypercholesterolemiaNew England Journal of Medicine, 1980
- Assessment of long-term plasma exchange for familial hypercholesterolaemia.Heart, 1980